Potential Breast Cancer Prevention Agent Found To Lower Levels Of 'Good' Cholesterol

[News]

Exemestane steadily lowered levels of "good" cholesterol in women taking the agent as part of a breast cancer prevention study, say researchers at Georgetown Lombardi Comprehensive Cancer Center. Exemestane, an aromatase inhibitor used to treat estrogen receptor-positive breast cancer, is being tested to prevent breast cancer in women at an increased risk of developing the disease...

More... (http://www.medicalnewstoday.com/releases/238945.php)